Logo image of KSCP

KNIGHTSCOPE INC-A (KSCP) Stock Fundamental Analysis

NASDAQ:KSCP - Nasdaq - US49907V2016 - Common Stock - Currency: USD

4.825  +0.34 (+7.7%)

After market: 4.85 +0.02 (+0.52%)

Fundamental Rating

3

Taking everything into account, KSCP scores 3 out of 10 in our fundamental rating. KSCP was compared to 83 industry peers in the Commercial Services & Supplies industry. The financial health of KSCP is average, but there are quite some concerns on its profitability. KSCP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year KSCP has reported negative net income.
In the past year KSCP has reported a negative cash flow from operations.
In the past 5 years KSCP always reported negative net income.
In the past 5 years KSCP always reported negative operating cash flow.
KSCP Yearly Net Income VS EBIT VS OCF VS FCFKSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -112.59%, KSCP is doing worse than 93.98% of the companies in the same industry.
KSCP has a worse Return On Equity (-201.09%) than 87.95% of its industry peers.
Industry RankSector Rank
ROA -112.59%
ROE -201.09%
ROIC N/A
ROA(3y)-108.33%
ROA(5y)-145.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KSCP Yearly ROA, ROE, ROICKSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

KSCP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KSCP Yearly Profit, Operating, Gross MarginsKSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

4

2. Health

2.1 Basic Checks

KSCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KSCP has less shares outstanding
The number of shares outstanding for KSCP has been reduced compared to 5 years ago.
The debt/assets ratio for KSCP is higher compared to a year ago.
KSCP Yearly Shares OutstandingKSCP Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KSCP Yearly Total Debt VS Total AssetsKSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -10.73, we must say that KSCP is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -10.73, KSCP is doing worse than 92.77% of the companies in the same industry.
A Debt/Equity ratio of 0.26 indicates that KSCP is not too dependend on debt financing.
KSCP's Debt to Equity ratio of 0.26 is fine compared to the rest of the industry. KSCP outperforms 63.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -10.73
ROIC/WACCN/A
WACC8.52%
KSCP Yearly LT Debt VS Equity VS FCFKSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

KSCP has a Current Ratio of 1.83. This is a normal value and indicates that KSCP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of KSCP (1.83) is better than 67.47% of its industry peers.
KSCP has a Quick Ratio of 1.61. This is a normal value and indicates that KSCP is financially healthy and should not expect problems in meeting its short term obligations.
KSCP has a Quick ratio of 1.61. This is in the better half of the industry: KSCP outperforms 69.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.61
KSCP Yearly Current Assets VS Current LiabilitesKSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

KSCP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -190.90%.
KSCP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.57%.
The Revenue has been growing by 28.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-190.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.71%
Revenue 1Y (TTM)-15.57%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%-6.64%

3.2 Future

The Earnings Per Share is expected to grow by 20.28% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 34.67% on average over the next years. This is a very strong growth
EPS Next Y42.77%
EPS Next 2Y20.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year27.91%
Revenue Next 2Y34.67%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
KSCP Yearly Revenue VS EstimatesKSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
KSCP Yearly EPS VS EstimatesKSCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KSCP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KSCP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KSCP Price Earnings VS Forward Price EarningsKSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KSCP Per share dataKSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8 -10

4.3 Compensation for Growth

KSCP's earnings are expected to grow with 20.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KSCP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KNIGHTSCOPE INC-A

NASDAQ:KSCP (4/17/2025, 8:00:02 PM)

After market: 4.85 +0.02 (+0.52%)

4.825

+0.34 (+7.7%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)N/A N/A
Inst Owners14.43%
Inst Owner Change0%
Ins Owners0.56%
Ins Owner Change0%
Market Cap33.29M
Analysts82.22
Price Target22.1 (358.03%)
Short Float %12.47%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.13%
Min EPS beat(2)-40.39%
Max EPS beat(2)60.65%
EPS beat(4)2
Avg EPS beat(4)-2.13%
Min EPS beat(4)-40.39%
Max EPS beat(4)60.65%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.58%
Min Revenue beat(2)-7.95%
Max Revenue beat(2)9.12%
Revenue beat(4)2
Avg Revenue beat(4)6.28%
Min Revenue beat(4)-33.04%
Max Revenue beat(4)57.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-88.44%
EPS NQ rev (1m)0.49%
EPS NQ rev (3m)16.25%
EPS NY rev (1m)0%
EPS NY rev (3m)32.3%
Revenue NQ rev (1m)2.64%
Revenue NQ rev (3m)-15.21%
Revenue NY rev (1m)7.01%
Revenue NY rev (3m)-20.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.08
P/FCF N/A
P/OCF N/A
P/B 2.11
P/tB 2.64
EV/EBITDA N/A
EPS(TTM)-10.86
EYN/A
EPS(NY)-6.22
Fwd EYN/A
FCF(TTM)-3.26
FCFYN/A
OCF(TTM)-3.25
OCFYN/A
SpS1.57
BVpS2.29
TBVpS1.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -112.59%
ROE -201.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-108.33%
ROA(5y)-145.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.64%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.61
Altman-Z -10.73
F-Score2
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)9.14%
Cap/Depr(5y)7.03%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-190.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.71%
EPS Next Y42.77%
EPS Next 2Y20.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.57%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%-6.64%
Revenue Next Year27.91%
Revenue Next 2Y34.67%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year11.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.05%
OCF growth 3YN/A
OCF growth 5YN/A